Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 175

1.

Estrogen regulation of Pak1 and FKHR pathways in breast cancer cells.

Mazumdar A, Kumar R.

FEBS Lett. 2003 Jan 30;535(1-3):6-10.

2.
3.

Expression of FKHR, FKHRL1, and AFX genes in the rodent ovary: evidence for regulation by IGF-I, estrogen, and the gonadotropins.

Richards JS, Sharma SC, Falender AE, Lo YH.

Mol Endocrinol. 2002 Mar;16(3):580-99.

PMID:
11875118
4.

Follicle-stimulating hormone promotes nuclear exclusion of the forkhead transcription factor FoxO1a via phosphatidylinositol 3-kinase in porcine granulosa cells.

Cunningham MA, Zhu Q, Unterman TG, Hammond JM.

Endocrinology. 2003 Dec;144(12):5585-94. Epub 2003 Sep 4.

PMID:
12960025
5.

Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance.

Campbell RA, Bhat-Nakshatri P, Patel NM, Constantinidou D, Ali S, Nakshatri H.

J Biol Chem. 2001 Mar 30;276(13):9817-24. Epub 2001 Jan 3.

6.

Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression.

Hutchinson J, Jin J, Cardiff RD, Woodgett JR, Muller WJ.

Mol Cell Biol. 2001 Mar;21(6):2203-12.

7.

FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal: protein kinase B-enhanced cell survival through maintenance of mitochondrial integrity.

Dijkers PF, Birkenkamp KU, Lam EW, Thomas NS, Lammers JW, Koenderman L, Coffer PJ.

J Cell Biol. 2002 Feb 4;156(3):531-42. Epub 2002 Jan 28.

8.
9.

Regulation of PGC-1 promoter activity by protein kinase B and the forkhead transcription factor FKHR.

Daitoku H, Yamagata K, Matsuzaki H, Hatta M, Fukamizu A.

Diabetes. 2003 Mar;52(3):642-9.

10.

FKHRL1 and its homologs are new targets of nerve growth factor Trk receptor signaling.

Zheng WH, Kar S, Quirion R.

J Neurochem. 2002 Mar;80(6):1049-61.

11.

Vascular endothelial growth factor activates PI3K/Akt/forkhead signaling in endothelial cells.

Abid MR, Guo S, Minami T, Spokes KC, Ueki K, Skurk C, Walsh K, Aird WC.

Arterioscler Thromb Vasc Biol. 2004 Feb;24(2):294-300. Epub 2003 Dec 1.

12.

Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B.

Rena G, Guo S, Cichy SC, Unterman TG, Cohen P.

J Biol Chem. 1999 Jun 11;274(24):17179-83.

13.

Inhibition of phosphatidylinositol 3'-kinase/AKT signaling promotes apoptosis of primary effusion lymphoma cells.

Uddin S, Hussain AR, Al-Hussein KA, Manogaran PS, Wickrema A, Gutierrez MI, Bhatia KG.

Clin Cancer Res. 2005 Apr 15;11(8):3102-8.

15.
16.
17.

Involvement of FKHR-dependent TRADD expression in chemotherapeutic drug-induced apoptosis.

Rokudai S, Fujita N, Kitahara O, Nakamura Y, Tsuruo T.

Mol Cell Biol. 2002 Dec;22(24):8695-708.

18.

Cellular models for the analysis of signaling by protein kinase B and the forkhead transcription factor FKHR (Foxo1a).

Orth HM, Kr├╝ger KD, Schmoll D, Grempler R, Scherbaum WA, Joost HG, Bornstein SR, Barthel A.

Regul Pept. 2004 Sep 15;121(1-3):19-24.

PMID:
15256269
19.
20.

FKHR (FOXO1a) is required for myotube fusion of primary mouse myoblasts.

Bois PR, Grosveld GC.

EMBO J. 2003 Mar 3;22(5):1147-57.

Supplemental Content

Support Center